| Literature DB >> 34768938 |
Pasquale D'Angelo1, Mario Barra2, Patrizia Lombari3,4, Annapaola Coppola3, Davide Vurro1, Giuseppe Tarabella5, Simone Luigi Marasso1, Margherita Borriello3, Federico Chianese6, Alessandra F Perna4, Antonio Cassinese2,6,7, Diego Ingrosso3.
Abstract
Homocysteine (Hcy) is a non-protein, sulfur-containing amino acid, which is recognized as a possible risk factor for coronary artery and other pathologies when its levels in the blood exceed the normal range of between 5 and 12 μmol/L (hyperhomocysteinemia). At present, standard procedures in laboratory medicine, such as high-performance liquid chromatography (HPLC), are commonly employed for the quantitation of total Hcy (tHcy), i.e., the sum of the protein-bound (oxidized) and free (homocystine plus reduced Hcy) forms, in biological fluids (particularly, serum or plasma). Here, the response of Aerosol Jet-printed organic electrochemical transistors (OECTs), in the presence of either reduced (free) and oxidized Hcy-based solutions, was analyzed. Two different experimental protocols were followed to this end: the former consisting of gold (Au) electrodes' biothiol-induced thiolation, while the latter simply used bare platinum (Pt) electrodes. Electrochemical impedance spectroscopy (EIS) analysis was performed both to validate the gold thiolation protocol and to gain insights into the reduced Hcy sensing mechanism by the Au-gated OECTs, which provided a final limit of detection (LoD) of 80 nM. For the OECT response based on Platinum gate electrodes, on the other hand, a LoD of 180 nM was found in the presence of albumin-bound Hcy, with this being the most abundant oxidized Hcy-form (i.e., the protein-bound form) in physiological fluids. Despite the lack of any biochemical functionalization supporting the response selectivity, the findings discussed in this work highlight the potential role of OECT in the development of low-cost point-of-care (POC) electronic platforms that are suitable for the evaluation, in humans, of Hcy levels within the physiological range and in cases of hyperhomocysteinemia.Entities:
Keywords: cardiovascular risk; homocysteine; organic electrochemical transistors; point-of-care testing
Mesh:
Substances:
Year: 2021 PMID: 34768938 PMCID: PMC8584102 DOI: 10.3390/ijms222111507
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Various forms of Homocysteine present in vivo. The albumin adduct oxidized derivative (protein bound) is, by far, the most prevalent, while the disulfide is normally almost negligible, except under some pathological conditions (e.g., homocystinuria). Although some authors hypothesized a role for either the protein-bound oxidized or the free forms, in clinical practice, total homocysteine is detected (tHcy), i.e., the sum of all forms, since current laboratory methods have been set up by accomplishing a preliminary reducing step (red arrows) prior to analytical procedures for quantitation.
Figure 2(a) Sketch of the OECT layout with Hcy-decorated Au- and bare Pt-gated electrodes used in this study. (b) Photograph of the OECT device connected to the probe-tip terminals (source and drain), showing the liquid electrolyte confined in the PDMS well and the Hcy-decorated gold gate electrode immersed in it; the inset shows a top-view picture of the real OECT.
Figure 3(a) Nyquist plot for the gold working electrodes of a SPE before (black symbols) and after (red symbols) their incubation in Hcy:HCl:PBS solutions (HCy concentration of 10 µM); continuous lines are the related fitting curves for the proposed equivalent circuit analysis; the inset shows a real picture of the commercial SPE used in this experiment. (b) Complex capacitance plot of the bare (black symbols) and covered (red symbols) electrodes calculated from the acquired complex impedances.
Fit parameters extracted from EIS equivalent circuit model analysis.
| Fit Parameters | SPE Au Bare | SPE Hcy-Functionalized |
|---|---|---|
| Rel (Ω) | 30.6 | 32.4 |
| Rct (MΩ) | 1.2 | 4.16 |
| CPE (Sxsn) | 5.9 | - |
| Ideality factor, n | 0.944 | 0.978 |
| CPEcoverage (Sxsn) | - | 1.68 |
| Relpores (KΩ) | - | 511 |
| CDL (nF) | - | 330 |
Figure 4(a) (solid lines) OECT transfer curves measured after the gate gold electrode incubation in Hcy:HCl:PBS solutions with progressively-increased Hcy concentrations (from 100 nM (black curve) to 1 mM (magenta curve); the dotted orange curve was measured at the end of this set of measurements and using a gold electrode incubated at 1µM of Hcy. (b) The IDS modulation parameter, defined as [(IDS(@VGS = 0.8 V) − (IDS(@VGS = 0.1 V)]/(IDS(@VGS = 0.1 V), extracted from all the recorded transfer curves in panel (a), as a function of the Hcy concentration in Hcy:HCl:PBS solutions.
Figure 5(a) OECT transfer curves measured with a platinum electrode in albumin-based solutions (at a fixed BSA concentration of 600 µM) at different Hcy concentrations (from 100 nM to 1 mM). (b) Lin-log plot of the modulation parameter ΔIDS, extracted from all the recorded transfer curves in panel (a), as a function of the Hcy concentration in BSA:PBS solutions. The dashed blue line represents the modulation parameter for the blank measurement (BSA in PBS).
List of the performed electrical tests.
| Investigated Device | Employed Solutions for the Electrical Tests | Main Goal |
|---|---|---|
| Screen-printed electrode after incubation in Hcy/HCl/PBS | PBS | To confirm that gold incubation in Hcy/HCl/PBS solutions promotes thiolation of the gold electrode |
| OECT with Au gate incubated in Hcy/HCl/PBS at differnet concentrations | PBS | To explore the sensitivity of OECT |
| OECT with bare Pt gate | Hcy:PBS:BSA with different concentrations | To explore the sensitivity of OECT vs. protein-bound Hcy |
| OECT with bare Pt gate | Hcy:HCl:PBS with different concentrations | To investigate the occurrence of oxidative processes involving free Hcy at the platinum surface |